Literature DB >> 975637

Selective severe cellular immunodeficiency. Effect of thymus transplantation and transfer factor administration.

J W Stoop, V P Eijsvoogel, B J Zegers, B Blok-Schut, D W van Bekkum, R E Ballieux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 975637     DOI： 10.1016/0090-1229(76)90081-7

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN： 0090-1229


× No keyword cloud information.
  6 in total

Review 1.  Combined immunodeficiency and inborn errors of purine metabolism.

Authors:  H J Meuwissen; B Pollara
Journal:  Blut       Date:  1978-10-13

2.  Erythrocyte metabolism in purine nucleoside phosphorylase deficiency after enzyme replacement therapy by infusion of erythrocytes.

Authors:  G E Staal; J W Stoop; B J Zegers; L H Siegenbeek van Heukelom; M J van der Vlist; S K Wadman; D W Martin
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

3.  Immunological investigation in adenine phosphoribosyl transferase (APRT) deficiency.

Authors:  W J Stevens; M E Peetermans; K J Van Acker
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

4.  Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.

Authors:  J M Wilson; B S Mitchell; P E Daddona; W N Kelley
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

5.  Human purine nucleoside phosphorylase cDNA sequence and genomic clone characterization.

Authors:  S R Williams; J M Goddard; D W Martin
Journal:  Nucleic Acids Res       Date:  1984-07-25       Impact factor: 16.971

6.  Purine nucleoside phosphorylase deficiency associated with a fatal lymphoproliferative disorder.

Authors:  A R Watson; D I Evans; H B Marsden; V Miller; P A Rogers
Journal:  Arch Dis Child       Date:  1981-07       Impact factor: 3.791
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.